Balazs R. Varga

Balazs R. Varga

Auto-generated profile, based on publicly available information

Balazs R. Varga

Center for Clinical Pharmacology, Department of Anesthesiology and Washington University Pain Center, Washington University School of Medicine, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2021 in eLife
Verified
Journal Article
Open access
RURajendra Uprety
Rajendra Uprety
TCTao Che
Tao Che
SZSaheem A Zaidi
Saheem A Zaidi
SGSteven G Grinnell
Steven G Grinnell
BVBalázs R Varga
Balázs R Varga
SMSusruta Majumdar
Susruta Majumdar
Controlling receptor functional selectivity profiles for opioid receptors is a promising approach for discovering safer analgesics; however, the structural determinants conferring functional selectivity are not well understood. Here, we used crystal structures of opioid receptors, including the recently solved active state kappa opioid complex with MP1104, to rationally design novel mixed mu (MOR) and kappa (KOR) opioid receptor agonists with reduced arrestin signaling. Analysis of structure-activity relationships for new MP1104 analogs points to a region between transmembrane 5 (TM5) and extracellular loop (ECL2) as key for modulation of arrestin recruitment to both MOR and KOR. The lead compounds, MP1207 and MP1208, displayed MOR/KOR Gi-partial agonism with diminished arrestin signaling, showed efficient analgesia with attenuated liabilities, including respiratory depression and conditioned place preference and aversion in mice. The findings validate a novel structure-inspired paradigm for achieving beneficial in vivo profiles for analgesia through different mechanisms that include bias, partial agonism, and dual MOR/KOR agonism.

30 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MRMichael J. Robertson
Michael J. Robertson
MPMakaía M. Papasergi-Scott
Makaía M. Papasergi-Scott
MPMaria Claudia Peroto
Maria Claudia Peroto
BVBalazs R. Varga
Balazs R. Varga
SMSusruta Majumdar
Susruta Majumdar
GSGeorgios Skiniotis
Georgios Skiniotis
Distinct ligands for the same G-protein coupled receptor (GPCR) activate intracellular signaling partners to varying extents, but the molecular mechanisms driving these differences remains elusive. Hypothesizing that such differences in signaling efficacy may be captured structurally in intermediate states under non-equilibrium conditions, we implemented a time-resolved (TR) cryo-EM approach to visualize the GTP-induced activation of the Gαiβγ heterotrimer by the μ-opioid receptor (MOR) bound to three ligands displaying partial, full, or super-agonism on the receptor. We resolved ensembles of conformational states along the G-protein activation pathway, including a previously unobserved intermediate state that enabled us to visualize receptor dynamics as a function of bound ligand. The results demonstrate ligand-dependent differences in state occupancy and conformational stability, with higher ligand efficacy correlating with increased dynamics of the receptor’s transmembrane (TM) helices 5 and 6. Furthermore, we identify key mechanistic differences in the GTP-induced activation of Gi compared to Gs that likely underlie their distinct activation kinetics. Corroborated by molecular dynamics (MD) simulations, these findings provide a dynamic structural landscape of GPCR-G-protein interactions for ligands of different efficacy and suggest partial agonists may produce a ‘kinetic trap’ during G-protein activation.